Topic Highlight
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jan 14, 2016; 22(2): 764-775
Published online Jan 14, 2016. doi: 10.3748/wjg.v22.i2.764
Table 3 Baseline characteristics of the Patients in the ACCORD-11 and MPACT trials
VariableACCORD-11(FOLFIRINOX)MPACT (Gemcitabine-Nab-paclitaxel)
Age
Median year (min, max)61 (25, 76)63 (27, 88)
≥ 65-yr-old29.0%42%
≥ 75-yr-old-10%
Performance status (ECOG)
037.4%16%
161.9%44%
232%
37%